In an unexpected development, two members of the Sackler family, which controls Purdue Pharma, will testify at a House hearing on Thursday about the role the company played in fueling the opioid crisis.
Former Purdue board members David Sackler and Kathe Sackler, along with Purdue chief executive officer Craig Landau, will appear virtually at the hearing scheduled by the Committee on Oversight and Reform. The committee, which investigated the drug maker and the extensive involvement of various Sackler family members in decision making, had threatened to issue subpoenas if they did not appear.
Their testimony may mark a watershed moment in the ongoing saga surrounding the notorious company and the secretive clan. Although court proceedings have previously divulged internal memos and depositions depicting the involvement of some Sackler family members in directing Purdue strategy — including a 2015 deposition of Richard Sackler made public by STAT and ProPublica — the hearing will be the first chance for the public to watch live as they respond to the string of accusations.
About the Author Reprints
